Value of Combined Thiazide-Loop Diuretic Therapy in Chronic Kidney Disease: Heart Failure and Renin-Angiotensin-Aldosterone Blockade

Journal of Clinical Hypertension

Volumn 14, Issue 5, 2012, Pages 344-

  Izzo, Joseph L ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYDROCHLOROTHIAZIDE; HYDROGEN; LOOP DIURETIC AGENT; POTASSIUM; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ACUTE KIDNEY FAILURE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIAGNOSTIC ERROR; DIURETIC THERAPY; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; HYPERKALEMIA; KIDNEY TUBULE ACIDOSIS; LETTER; NATRIURESIS; POTASSIUM BALANCE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM RESTRICTION;

BLOOD PRESSURE; FEMALE; FUROSEMIDE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; KIDNEY DISEASES; MALE; NATRIURESIS;

EID: 84860323032     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2012.00614.x     Document Type: Letter

References (1)

1. Dussol B, Moussl-Frances J, Morange S, et al. A pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease. J Clin Hypertens (Greenwich). 2012;14:32-37.